Skip navigation

Request Info

Tests Explore all tests

Systems Explore all systems

Solutions A Passion for Better Patient Care

Insights Explore All Insights

Support Get Customer Support

About Us Request Information

Respiratory

HAI & Other Infectious Diseases

Blood Virology, Women's Health, & Sexual Health

TB & Emerging Infectious Diseases

Oncology & Human Genetics

Cepheid GeneXpert Systems

GeneXpert® System Software

Cepheid Connectivity and Interface Capabilities

partner-communities

Global Access

Eligibility & Pricing

Testing Everywhere

Antibiotic Stewardship

Oncology Diagnostics

Customized Testing for Your Institution

Knowing MORE Matters

Insight Hub

Resources

Webinars

Self-Service Support

Safety Data Sheets

Upload Instrument Data

IVDR Update

Specimen Collection

Certificate of Analysis

Mission and History

Our Leadership

Our Leadership

Sustainability

Business Development Opportunities

Meet the Cepheid Bike

Distributors

News

Events

Innovate with Cepheid

Careers

Our Leadership

Request Info

Xpert® Breast Cancer STRAT4

Order Now

Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours

Insights

12m Read

June 16, 2025

COMMUNITY AND GLOBAL HEALTH

Women’s Health Testing: Advantages of same-day diagnosis and treatment, Frost & Sullivan Visual Whitepaper

40m Read

May 21, 2025

COMMUNITY AND GLOBAL HEALTH

{{getSidebarNestedSelection() || 'Main menu'}}

Location / Language

Xpert® Breast Cancer STRAT4

Connect To Better Outcomes

Insights

Women’s Health Testing: Advantages of same-day diagnosis and treatment, Frost & Sullivan Visual Whitepaper

Decentralising Diagnostics: Bringing Patient-Centred Testing Closer to Communities